Comparison of Mass Spectrometry and Clinical Assay Measurements of Circulating Fragments of B-Type Natriuretic Peptide in Patients With Chronic Heart Failure
Open accessThe DOI matches its Crossref record.
Abstract
Background—: Multiple B-type natriuretic peptide (BNP) fragments circulate in patients with heart failure (HF) but the types and relative quantities, particularly in relation to bioactive BNP 1-32, remain poorly defined. The purpose of the study was to relate clinically available BNP values with quantitative information on the concentration of pre-secretion and post-processed fragments of BNP detected by mass spectrometry. Methods and Results—: Seventy Class I–IV patients were prospectively enrolled with blood drawn into tubes containing a preservative to protect against BNP degradation. Samples were analyzed by quantitative mass spectrometry (MS) immunoassay for intact BNP 1-32 and its fragments. Clinical BNP 1-2 was measured by standard clinical laboratory methods. ProBNP 1-108, corin, and clinically measured BNP levels were elevated, but MS BNP 1-32 levels were low and differed from clinical BNP ( P =0.01). Intact MS BNP 1-32 correlated modestly with clinical BNP ( r =0.46, P <0.001). MS BNP fragments 3-32, 4-32, and 5-32 demonstrated the best associations with clinical BNP; fragment 5-32 with a correlation coefficient of r =0.81 ( P <0.001). Conclusions—: ProBNP 1-108 is measured by clinical BNP assays and contributes to the cumulative results of the BNP assay. However, the observation that clinically measured BNP correlates best with MS degradation fragments and relatively poorly with MS BNP 1-32 suggests that a significant component of circulating clinical BNP is composed of such fragments that are known to demonstrate little biological activity. There appear to be multiple pathways involved in the dysregulation of proBNP in HF, and both the processing of proBNP and the downstream degradation to BNP 1-32 appear to be critical.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mangiafico, S., Costello-Boerrigter, L. C., Andersen, I. A., Cataliotti, A., & Burnett, J. C. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs262 · Cited by 276
Natriuretic peptides in cardiometabolic regulation and disease
Zois, N. E., Bartels, E. D., Hunter, I., Kousholt, B. S., Olsen, L. H., & Goetze, J. P. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.64 · Cited by 182
Applications of MALDI Mass Spectrometry in Clinical Chemistry
Duncan, M. W., Nedelkov, D., Walsh, R., & Hattan, S. J. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.239491 · Cited by 96
Cardiovascular biomarkers in clinical studies of type 2 diabetes
Baldassarre, M. P. A., Andersen, A., Consoli, A., Knop, F. K., & Vilsbøll, T. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13247 · Cited by 22
“EDTA plasma produces predictably lower NTproBNP values (10%-13%) than those observed in serum or heparin plasma, which may be explained by NT-proBNP fragmentation after samples are drawn.(22) Additionally, heparinized whole blood can be analysed in point-of-care systems, a portable device measuring NTproBNP in real ti…”
Background
Metadata
- Authors
- Miller, W. L., Phelps, M. A., Wood, C. M., Schellenberger, U., Van Le, A., Perichon, R., & Jaffe, A. S.
- Venue
- Circulation: Heart Failure
- Published
- 2011-05
- Volume
- 4
- Issue
- 3
- Pages
- 355-360
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2168156050
- Cited by
- 121
- References
- 0
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of Mass Spectrometry and Clinical Assay Measurements of Circulating Fragments of B-Type Natriuretic Peptide in Patients With Chronic Heart Failure. https://app.cochat.ai/papers/10.1161/circheartfailure.110.960260
- The paper
- Miller, W. L., Phelps, M. A., Wood, C. M., Schellenberger, U., Van Le, A., Perichon, R., & Jaffe, A. S. (2011). Comparison of Mass Spectrometry and Clinical Assay Measurements of Circulating Fragments of B-Type Natriuretic Peptide in Patients With Chronic Heart Failure. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.110.960260
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.